Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease

Background: Cancer treatments induce symptoms/signs superimposing on individual patient's clinical status, determining heterogenous toxicity syndromes (TS). We reviewed intensive first line triplet chemotherapy-based regimens in metastatic gastro-intestinal cancers (mGI), based on FIr/FOx sched...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruera, Gemma, Ricevuto, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044407/
https://www.ncbi.nlm.nih.gov/pubmed/32154172
http://dx.doi.org/10.3389/fonc.2020.00172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044407/
https://www.ncbi.nlm.nih.gov/pubmed/32154172
http://dx.doi.org/10.3389/fonc.2020.00172

Ejemplares similares